Drug
SSGJ-707
SSGJ-707 is a pharmaceutical drug with 5 clinical trials. Currently 5 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
5(100%)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
4
80%
Phase Distribution
0
Early Stage
4
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
5
trials recruiting
Total Trials
5
all time
Status Distribution
Active(5)
Detailed Status
Recruiting5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
5
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 24 (80.0%)
Phase 31 (20.0%)
Trials by Status
recruiting5100%
Recent Activity
5 active trials
Showing 5 of 5
recruitingphase_3
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
NCT06980272
recruitingphase_2
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
NCT06522828
recruitingphase_2
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
NCT06493760
recruitingphase_2
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients
NCT06412471
recruitingphase_2
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
NCT06361927
Clinical Trials (5)
Showing 5 of 5 trials
NCT06980272Phase 3
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
NCT06522828Phase 2
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
NCT06493760Phase 2
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
NCT06412471Phase 2
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients
NCT06361927Phase 2
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5